These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6097162)

  • 1. Metabolism of [14C]Cefmenoxime in normal subjects after intramuscular administration.
    Machinist JM; Bopp BA; Quinn D
    Antimicrob Agents Chemother; 1984 Oct; 26(4):431-5. PubMed ID: 6097162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic study of cefmenoxime (SCE 1365-CMX) in healthy adults.
    Fourtillan JB; Bryskier A; Mignot A; Borsa F; Humbert G
    Am J Med; 1984 Dec; 77(6A):28-31. PubMed ID: 6097120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of SCE-1141, a stereoisomer of cefmenoxime, in rats.
    Kita Y; Itakura K; Tsuchiya K; Imada A
    J Antimicrob Chemother; 1986 Feb; 17(2):205-13. PubMed ID: 3457784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intramuscular and intravenous pharmacokinetics of cefmenoxime, a new broad-spectrum cephalosporin, in healthy subjects.
    Granneman GR; Sennello LT; Steinberg FJ; Sonders RC
    Antimicrob Agents Chemother; 1982 Jan; 21(1):141-5. PubMed ID: 6282203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition and metabolism of [14C]-haloperidol in rats.
    Miyazaki H; Matsunaga Y; Nambu K; Oh-e Y; Yoshida K; Hashimoto M
    Arzneimittelforschung; 1986 Mar; 36(3):443-52. PubMed ID: 3707663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic fate of SCE-1365, a new broad-spectrum cephalosporin, after parenteral administration to rats and dogs.
    Tanayama S; Yoshida K; Adachi K; Kondo T
    Antimicrob Agents Chemother; 1980 Oct; 18(4):511-8. PubMed ID: 6934706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefmenoxime kinetics during continuous ambulatory peritoneal dialysis.
    Sica DA; Polk RE; Kerkering TM; Patterson P; Baggett J
    Eur J Clin Pharmacol; 1986; 30(6):713-7. PubMed ID: 3464435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefmenoxime pharmacokinetics in healthy volunteers and subjects with renal insufficiency and on hemodialysis.
    Gambertoglio JG; Alexander DP; Barriere SL
    Antimicrob Agents Chemother; 1984 Dec; 26(6):845-9. PubMed ID: 6098220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma and skin blister fluid levels of cefotiam and cefmenoxime after single intramuscular application of 1 g in gonorrhea.
    Korting HC
    Chemotherapy; 1984; 30(5):277-82. PubMed ID: 6092005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review.
    Setnikar I; Rovati LC
    Arzneimittelforschung; 2001 Sep; 51(9):699-725. PubMed ID: 11642003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefmenoxime pharmacokinetics in patients with renal insufficiency.
    Polk RE; Sica DA; Kerkering TM; Kline BJ; Patterson PM; Baggett JW
    Antimicrob Agents Chemother; 1984 Sep; 26(3):322-7. PubMed ID: 6095752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excretion and metabolism of intramuscularly administered [14C]-haloperidol decanoate in rats.
    Matsunaga Y; Nambu K; Oh-e Y; Miyazaki H; Hashimoto M
    Arzneimittelforschung; 1986 Mar; 36(3):453-6. PubMed ID: 3707664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetic study of cefmenoxime concerning its transfer into tissues].
    Washida H; Tsugaya M; Hirao N; Sakagami H; Iwase Y
    Jpn J Antibiot; 1985 Jun; 38(6):1648-53. PubMed ID: 3862883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetics of cefmenoxime in the aged subject (60 to 90 years of age) after an intravenous injection of 1 g].
    Veyssier P; Bryskier A; Modai J; Boquet A; Fourtillan JB
    Pathol Biol (Paris); 1986 Dec; 34(10):1081-3. PubMed ID: 3547264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of probenecid on the pharmacokinetics of cefmenoxime.
    Sennello LT; Quinn D; Rollins DE; Tolman KG; Sonders RC
    Antimicrob Agents Chemother; 1983 Jun; 23(6):803-7. PubMed ID: 6311084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass balance study of [¹⁴C]eribulin in patients with advanced solid tumors.
    Dubbelman AC; Rosing H; Jansen RS; Mergui-Roelvink M; Huitema AD; Koetz B; Lymboura M; Reyderman L; Lopez-Anaya A; Schellens JH; Beijnen JH
    Drug Metab Dispos; 2012 Feb; 40(2):313-21. PubMed ID: 22041109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.
    Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A
    Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absorption, metabolism and excretion after oral administration of a new Ca antagonist, 14C-benidipine hydrochloride to man.
    Kobayashi H; Kobayashi S; Dalrymple PD; Wood SG; Chasseaud LF
    Xenobiotica; 1997 Jun; 27(6):597-608. PubMed ID: 9211659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition of a low dose of bisphenol a in male and female cynomolgus monkeys.
    Kurebayashi H; Harada R; Stewart RK; Numata H; Ohno Y
    Toxicol Sci; 2002 Jul; 68(1):32-42. PubMed ID: 12075108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.